Dr. Luo and Dr. Miller will provide guidance to the manufacturing of ECDI-fixed donor cell vaccines using cell products generated from donor pigs. In addition, they will oversee (1) delayed type hypersensitivity assays; and (2) B cell ELISPOT assays to quantify xenogeneic anti-donor T and B cell responses using in vivo and in vitro study models.
|Effective start/end date||7/1/15 → 6/30/20|
- University of Minnesota (N004761502//5U01AI20130-04)
- National Institute of Allergy and Infectious Diseases (N004761502//5U01AI20130-04)